ANKZF1 was first reported in relation to undetermined mode of inheritance inflammatory bowel disease in 2017 (Van Haaften-Visser DY et al. PMID: 28302725). Van Haaften-Visser specifies in the publication that their version of IBD is infantile onset, however there is no current MONDO term for IO-IBD.
Four missense and one deletion variant that have been reported in four probands in one publication (PMID: 28302725) are included in this curation. The probands all presented with symptoms within the first six months of life. The female proband’s symptoms include lymphopenia, gastric and oral ulcers, abnormal T-, NK-, and B- cell counts, decreased circulating antibody concentration, bloody diarrhea, and mucus in stool. The male proband's symptoms include pancolitis. Two of the probands are said to be diagnosed with IO-IBD, but do not have any symptoms noted in the paper.
Minimal evidence for a causal role for ANKZF1 in infantile-onset inflammatory bowel disease has been reported. Although this gene-disease relationship is supported by the female patient with ANKZF1 mRNA and protein expression being reduced in a homozygous R585Q mutation. The other three probands were either heterozygous, or compound heterozygous with no functional evidence available to show expression. Therefore, no reports have directly implicated the gene in humans, and the mode of inheritance is undetermined.
This classification was approved by the ClinGen PIRD GCEP on the meeting date April 15th, 2025 (SOP Version 11).
The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.